GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 78 filers reported holding GENERATION BIO CO in Q3 2023. The put-call ratio across all filers is 2.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,234 | +53.6% | 10,352 | +122.9% | 0.00% | – |
| Q2 2023 | $25,547 | +50.3% | 4,645 | +46.7% | 0.00% | – |
| Q3 2022 | $17,000 | -5.6% | 3,167 | +375.5% | 0.00% | – |
| Q2 2021 | $18,000 | -18.2% | 666 | -14.2% | 0.00% | – |
| Q1 2021 | $22,000 | +450.0% | 776 | +417.3% | 0.00% | – |
| Q4 2020 | $4,000 | -66.7% | 150 | -60.0% | 0.00% | – |
| Q3 2020 | $12,000 | +50.0% | 375 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | – | 375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $32,535,983 | 3.92% |
| GREAT POINT PARTNERS LLC | 1,022,537 | $4,018,570 | 0.79% |
| Artal Group S.A. | 2,814,191 | $11,060 | 0.62% |
| SVB FINANCIAL GROUP | 52,920 | $207,976 | 0.57% |
| PFM Health Sciences, LP | 2,903,192 | $11,409,545 | 0.41% |
| Cheyne Capital Management (UK) LLP | 51,126 | $200,925 | 0.35% |
| HighVista Strategies LLC | 138,880 | $545,798 | 0.32% |
| HARVARD MANAGEMENT CO INC | 510,354 | $2,005,691 | 0.25% |
| SECTORAL ASSET MANAGEMENT INC | 273,787 | $1,075,983 | 0.21% |
| Yiheng Capital Management, L.P. | 1,186,295 | $4,662,139 | 0.21% |